Automation unlocks agility in microbiome and biotech R&D

For pharma leaders chasing faster discovery and scale, manual colony picking has long been a bottleneck, slow, error-prone, and resource-intensive. Molecular Devices’ new QPix FLEX system changes the game. Compact enough for tight labs and anaerobic chambers, it automates end-to-end microbial screening with precision, sterility, and full traceability. From microbiome research to synthetic biology, QPix FLEX empowers leaner teams to do more, faster—without compromising data integrity or lab standards.

Read the full article to see how automation is reshaping early-stage biotech.